查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年亚太地区透皮给药系统市场预测 - 区域分析 - 按类型、应用和配销通路
市场调查报告书
商品编码
1510743

2030 年亚太地区透皮给药系统市场预测 - 区域分析 - 按类型、应用和配销通路

Asia Pacific Transdermal Drug Delivery System Market Forecast to 2030 - Regional Analysis - by Type, Application, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 112 Pages | 订单完成后即时交付

价格

亚太地区透皮给药系统市场预计将从2022年的90.2989亿美元成长到2030年的128.2077亿美元。

智慧贴片和 3D 列印贴片的进步推动亚太地区透皮给药系统市场

经皮给药途径是新颖的，也是持续给药的可靠方法之一。随着这一领域的大量研究的开展以及研究人员对这种药物输送形式的兴趣日益浓厚，未来可能会有大量透皮贴片进入市场。透皮贴片用于输送尼古丁、芬太尼、硝酸甘油和可乐定等药物来治疗各种疾病。最近，这些贴片已被探索在各种应用中提供生物製剂。智慧贴片配备了感测器和其他技术来监测患者状况并相应调整药物传递。 2023 年 1 月，斯旺西大学的一位首席科学家开发了一种新型智慧贴片，利用微针技术检测帕金森氏症和阿兹海默症等神经退化性疾病的促炎生物标记。这些智慧贴片包含大量微针，旨在以微创方式穿透皮肤屏障，然后监测具有临床意义的生物标记。它们可以在全科诊所或家中自我管理以进行即时诊断。这项创新研究可能会改变早期神经退化性疾病检测的格局。

根据2021年11月发表在美国国家医学图书馆的一篇题为《局部皮肤应用的3D列印产品：从个人化敷料到药物输送》的文章称，贴合皮肤表面的个人化3D列印贴片可用于乙酰化-六肽3 (AHP-3) 递送。在这项研究中，两种液体单体——聚乙二醇二丙烯酸酯（PEGDA）和乙烯基吡咯烷酮（VP）——以不同的比例使用，以提高最终聚合物的机械强度、聚合速率和溶胀速率。树脂上的最佳载药量表明 AHP-3 在整个製造过程中保持稳定，并且对最终聚合物的物理性能没有影响。使用 3D 扫描脸部模型，在电脑辅助设计软体中设计个人化贴片，并使用数位光处理 3D 列印机以优化树脂製造。製备的透皮贴片的体外表征表明它们能够穿透人体尸体皮肤，并在压缩后进一步保持完整。 「用于局部皮肤应用的3D 列印产品：从个人化敷料到药物输送」是第一个展示使用光聚合物製成的个人化贴片的研究，它引入了一种改进药物透皮输送的新方法，以实现有效的皱纹管理。

因此，3D列印技术和智慧贴片的采用可能会在未来几年为透皮给药系统市场提供机会。

亚太地区透皮给药系统市场概况

亚太地区透皮给药系统市场分为中国、日本、印度、澳洲、韩国和亚太其他地区。由于人口老化加剧、心血管疾病盛行率增加以及对非侵入性医疗设备的需求不断增加，预计中国、印度和澳洲等国家的市场将成长最快。在亚太地区，中国是最大的经皮给药系统市场。中国透皮给药系统市场的成长主要归因于该国技术的不断发展，市场参与者不断开发用于疼痛管理的透皮贴片和半固体产品。

此外，在过去几年中，中国的公司正在进行产品上市和批准、收购、合作和合併，以扩大其在透皮给药系统产业的业务。例如，2022年1月，苏州瑞维达医疗器材有限公司（REVEDA）宣布与翰宇药业股份有限公司（简称「翰宇药业」）合作成立药械组合产品合资公司，并在药械组合产品领域展开合作。 REVEDA Medical将持有合资公司60%的股份，Hybio Pharmaceutical将持有40%的股份。此外，2021年9月，英国药品和保健品监管局批准绿叶製药集团创新製剂卡巴拉汀多日透皮贴片（卡巴拉汀MD）上市，用于治疗与阿兹海默症相关的轻至中度痴呆。一些欧盟国家已经获得了该药物的上市许可。因此，由于上述因素，预计未来几年市场将推动该国对透皮给药系统的需求。

亚太地区透皮给药系统市场收入及 2030 年预测（百万美元）

亚太地区透皮给药系统市场区隔

亚太地区透皮给药系统市场按类型、应用、配销通路和国家细分。

根据类型，亚太地区透皮给药系统市场分为透皮贴片、透皮凝胶、透皮喷雾等。到2022年，透皮凝胶细分市场将占据亚太地区透皮给药系统市场的最大份额。贴剂。

从应用来看，亚太地区透皮给药系统市场分为心血管疾病、中枢神经系统疾病、疼痛管理、荷尔蒙应用和其他应用。到2022年，疼痛管理细分市场将占据亚太地区透皮给药系统市场的最大份额。荷尔蒙应用进一步细分为透皮雌激素和黄体素治疗以及睪固酮替代疗法。

依配销通路，亚太地区透皮给药系统市场分为医院药局、零售药局、网路药局等。 2022年，医院药局部门在亚太地区透皮给药系统市场中占有最大份额。

依国家/地区划分，亚太地区透皮给药系统市场分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。 2022年，中国将主导亚太地区透皮给药系统市场。

勃林格殷格翰国际有限公司、葛兰素史克公司、久光製药有限公司、强生公司、绿叶製药集团有限公司、诺华公司和 Viatris Inc 是亚太地区透皮给药系统市场的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：亚太地区透皮给药系统市场 - 主要产业动态

  • 市场驱动因素
    • 慢性病盛行率增加
    • 对非侵入性给药设备的需求不断增长
    • 自我用药需求旺盛
  • 市场限制
    • 经皮给药系统的不良反应与召回
  • 市场机会
    • 智慧补丁和 3D 列印补丁的进步
  • 未来的趋势
    • 製造商的策略倡议
  • 影响分析

第 5 章：透皮给药系统市场 - 亚太地区市场分析

  • 亚太地区透皮给药系统市场收入，2022 - 2030

第 6 章：亚太地区透皮给药系统市场 - 收入和 2030 年预测 - 按类型

  • 概述
  • 2022 年和 2030 年亚太地区透皮给药系统市场收入份额（按类型）（%）
  • 透皮贴剂
  • 透皮凝胶
  • 透皮喷剂
  • 其他的

第 7 章：亚太地区透皮给药系统市场 - 收入和 2030 年预测 - 按应用

  • 概述
  • 2022 年及 2030 年亚太地区透皮给药系统市场收入份额（按应用划分）（%）
  • 心血管疾病
  • 中枢神经系统疾病
  • 疼痛管理
  • 荷尔蒙应用
  • 其他应用

第 8 章：亚太地区透皮给药系统市场 - 2030 年收入与预测 - 按配销通路

  • 概述
  • 2022 年及 2030 年亚太地区透皮给药系统市场收入份额（按配销通路） （%）
  • 医院药房
  • 零售药局
  • 网路药局
  • 其他的

第 9 章：亚太地区透皮给药系统市场 - 收入与 2030 年预测 - 国家分析

  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区

第 10 章：透皮给药系统市场产业格局

  • 概述
  • 透皮给药系统市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 11 章：公司简介

  • Novartis AG
  • Johnson & Johnson
  • GSK Plc
  • Viatris Inc
  • Boehringer Ingelheim International GmbH
  • Hisamitsu Pharmaceutical Co Inc
  • Luye Pharma Group Ltd

第 12 章：附录

Product Code: TIPRE00013002

The Asia Pacific transdermal drug delivery system market is expected to grow from US$ 9,029.89 million in 2022 to US$ 12,820.77 million by 2030. It is estimated to register a CAGR of 4.5% from 2022 to 2030.

Advancements in Smart Patches and 3D-Printed Patches Fuel Asia Pacific Transdermal Drug Delivery System Market

A transdermal drug administration route is novel and one of the reliable means of sustained drug delivery. With significant research being conducted in this field and the increasing interest of researchers in this form of drug delivery, a large number of transdermal patches are likely to reach the marketplace in the future. Transdermal patches are used to deliver drugs such as nicotine, fentanyl, nitroglycerin, and clonidine to treat various medical conditions. Recently, these patches have been explored to deliver biologics in various applications. Smart patches are equipped with sensors and other technologies to monitor patient conditions and adjust drug delivery accordingly. In January 2023, a lead scientist at Swansea University developed a new smart patch to detect proinflammatory biomarkers of neurodegenerative diseases such as Parkinson's and Alzheimer's using the microneedle technology. These smart patches comprise numerous microneedles designed to penetrate the skin barrier in a minimally invasive manner, followed by monitoring the biomarkers of clinical significance. They can be self-administered for point-of-care diagnosis at general practices or at home. This innovative research can potentially change the landscape of early neurodegenerative disease detection.

According to an article titled "3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery," published in the National Library of Medicine in November 2021, personalized 3D-printed patches that conform to the skin surface can be used for acetyl-hexapeptide 3 (AHP-3) delivery. In this study, two liquid monomers-polyethylene glycol diacrylate (PEGDA) and vinylpyrrolidone (VP)-were used in different proportions to improve the mechanical strength, polymerization rate, and swelling rate of the final polymer. Optimal drug loading on the resin indicated that AHP-3 remained stable throughout the manufacturing process and had no effect on the physical properties of the final polymer. Using a 3D scanned facial model, a personalized patch was designed in computer-aided design software, and it was fabricated in optimized resin using a digital light processing 3D printer. The in-vitro characterization of prepared transdermal patches has shown their ability to penetrate human cadaver skin, further remaining intact upon compression. "3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery" is the first study demonstrating personalized patches made using photopolymers, and it has introduced a novel approach to improve the transdermal delivery of drugs for effective wrinkle management.

Thus, the adoption of 3D printing technology and smart patches is likely to offer opportunities to the transdermal drug delivery systems market in the coming years.

Asia Pacific Transdermal Drug Delivery System Market Overview

The Asia Pacific transdermal drug delivery systems market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth is expected to be fastest in countries such as China, India, and Australia due to growing aging population, increasing prevalence of cardiovascular diseases, and increasing demand for non-invasive medical devices. In Asia Pacific, China is the largest market of transdermal drug delivery systems. The growth of the transdermal drug delivery system market in China is primarily attributed to the growing technology in the country, increasing developments by the market players to develop transdermal patches and semisolid products for pain management.

Also, in the last few years, companies in China are undergoing product launches and approvals, acquisitions, partnerships, and mergers to expand their business in the transdermal drug delivery systems industry. For instance, in January 2022, Suzhou Reveda Medical Co., Ltd. (REVEDA) announced that it partnered with Hybio Pharmaceutical Co., Ltd. (Hybio Pharmaceutical) to set up a joint venture for drug-device combination products and team up in the field of polypeptide micro-needles for transdermal delivery. 60% of the joint venture will be owned by REVEDA Medical and 40% by Hybio Pharmaceutical. Furthermore, in September 2021, the UK's Medicines and Healthcare Products Regulatory Agency granted marketing approval for Luye Pharma Group's innovative formulation Rivastigmine Multi-Day Transdermal Patch (Rivastigmine MD) for the treatment of mild to moderate dementia associated with Alzheimer's disease. Several European Union nations already have marketing authorization for the medicine. Thus, owing to the abovementioned factors, the market is expected to propel the demand for transdermal drug delivery systems in this country in the upcoming years.

Asia Pacific Transdermal Drug Delivery System Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Transdermal Drug Delivery System Market Segmentation

The Asia Pacific transdermal drug delivery system market is segmented into type, application, distribution channel, and country.

Based on type, the Asia Pacific transdermal drug delivery system market is segmented into transdermal patches, transdermal gel, transdermal sprays, and others. The transdermal gel segment held the largest share of the Asia Pacific transdermal drug delivery system market in 2022. The transdermal patches is further sub segmented into drug-in-adhesive patches, matrix patches, reservoir membrane patches, and vapor patches.

In terms of application, the Asia Pacific transdermal drug delivery system market is categorized into cardiovascular diseases, central nervous system disorders, pain management, hormonal applications, and other applications. The pain management segment held the largest share of the Asia Pacific transdermal drug delivery system market in 2022. The pain management is further sub segmented into opioid and non-opioid. The hormonal applications is further sub segmented into transdermal estrogen & progesterone therapy and testosterone replacement.

By distribution channel, the Asia Pacific transdermal drug delivery system market is segmented into hospitals pharmacies, retail pharmacies, online pharmacies, and others. The hospitals pharmacies segment held the largest share of the Asia Pacific transdermal drug delivery system market in 2022.

Based on country, the Asia Pacific transdermal drug delivery system market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific transdermal drug delivery system market in 2022.

Boehringer Ingelheim International GmbH, GSK Plc, Hisamitsu Pharmaceutical Co Inc, Johnson & Johnson, Luye Pharma Group Ltd, Novartis AG, and Viatris Inc are some of the leading companies operating in the Asia Pacific transdermal drug delivery system market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Transdermal Drug Delivery System Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Prevalence of Chronic Diseases
    • 4.1.2 Growing Demand for Noninvasive Drug Delivery Devices
    • 4.1.3 High Demand for Self-Administration of Drugs
  • 4.2 Market Restraints
    • 4.2.1 Adverse Effects and Recall of Transdermal Drug Delivery Systems
  • 4.3 Market Opportunities
    • 4.3.1 Advancements in Smart Patches and 3D-Printed Patches
  • 4.4 Future Trends
    • 4.4.1 Strategic Initiatives by Manufacturers
  • 4.5 Impact Analysis

5. Transdermal Drug Delivery System Market - Asia Pacific Market Analysis

  • 5.1 Asia Pacific Transdermal Drug Delivery System Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Type

  • 6.1 Overview
  • 6.2 Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
  • 6.3 Transdermal Patches
    • 6.3.1 Overview
    • 6.3.2 Transdermal Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 Drug-in-Adhesive Patches
        • 6.3.2.1.1 Overview
        • 6.3.2.1.2 Drug-in-Adhesive Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.2 Matrix Patches
        • 6.3.2.2.1 Overview
        • 6.3.2.2.2 Matrix Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.3 Reservoir Membrane Patches
        • 6.3.2.3.1 Overview
        • 6.3.2.3.2 Reservoir Membrane Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.4 Vapor Patches
        • 6.3.2.4.1 Overview
        • 6.3.2.4.2 Vapor Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Transdermal Gels
    • 6.4.1 Overview
    • 6.4.2 Transdermal Gels: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Transdermal Sprays
    • 6.5.1 Overview
    • 6.5.2 Transdermal Sprays: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Others
    • 6.6.1 Overview
    • 6.6.2 Others: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Application

  • 7.1 Overview
  • 7.2 Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
  • 7.3 Cardiovascular Diseases
    • 7.3.1 Overview
    • 7.3.2 Cardiovascular Diseases: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Central Nervous System Disorders
    • 7.4.1 Overview
    • 7.4.2 Central Nervous System Disorders: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Pain Management
    • 7.5.1 Overview
    • 7.5.2 Pain Management: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.5.2.1 Opioid
        • 7.5.2.1.1 Overview
        • 7.5.2.1.2 Opioid: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.5.2.2 Non-Opioid
        • 7.5.2.2.1 Overview
        • 7.5.2.2.2 Non-Opioid: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Hormonal Applications
    • 7.6.1 Overview
    • 7.6.2 Hormonal Applications: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.6.2.1 Transdermal Estrogen & Progesterone Therapy
        • 7.6.2.1.1 Overview
        • 7.6.2.1.2 Transdermal Estrogen & Progesterone Therapy: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.6.2.2 Testosterone Replacement
        • 7.6.2.2.1 Overview
        • 7.6.2.2.2 Testosterone Replacement: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Other Application
    • 7.7.1 Overview
    • 7.7.2 Other Application: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 8.1 Overview
  • 8.2 Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 8.3 Hospital Pharmacies
    • 8.3.1 Overview
    • 8.3.2 Hospital Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Retail Pharmacies
    • 8.4.1 Overview
    • 8.4.2 Retail Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Online Pharmacies
    • 8.5.1 Overview
    • 8.5.2 Online Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - Country Analysis

  • 9.1 Asia Pacific Transdermal Drug Delivery System Market
    • 9.1.1 Asia Pacific Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
      • 9.1.1.1 China: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.1.1 Overview
        • 9.1.1.1.2 China: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.1.3 China: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.1.3.1 China: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.1.4 China: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.1.4.1 China: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.1.4.2 China: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.1.5 China: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 9.1.1.2 Japan: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 Japan: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.2.3 Japan: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.2.3.1 Japan: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.2.4 Japan: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.2.4.1 Japan: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.2.4.2 Japan: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.2.5 Japan: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 9.1.1.3 India: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 India: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.3.3 India: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.3.3.1 India: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.3.4 India: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.3.4.1 India: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.3.4.2 India: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.3.5 India: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 9.1.1.4 Australia: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 Australia: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.4.3 Australia: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.4.3.1 Australia: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.4.4 Australia: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.4.4.1 Australia: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.4.4.2 Australia: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.4.5 Australia: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 9.1.1.5 South Korea: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.5.1 Overview
        • 9.1.1.5.2 South Korea: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.5.3 South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.5.3.1 South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.5.4 South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.5.4.1 South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.5.4.2 South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.5.5 South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 9.1.1.6 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.6.1 Overview
        • 9.1.1.6.2 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.6.3 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.6.3.1 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.6.4 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.6.4.1 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.6.4.2 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.6.5 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)

10. Transdermal Drug Delivery System Market Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Transdermal Drug Delivery System Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Novartis AG
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Johnson & Johnson
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 GSK Plc
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Viatris Inc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Boehringer Ingelheim International GmbH
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Hisamitsu Pharmaceutical Co Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Luye Pharma Group Ltd
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Transdermal Drug Delivery System Market Segmentation
  • Table 2. China: Asia Pacific Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. China: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. China: Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. China: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. China: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. China: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Japan: Asia Pacific Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Japan: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Japan: Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Japan: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Japan: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Japan: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. India: Asia Pacific Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. India: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. India: Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. India: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. India: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. India: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Australia: Asia Pacific Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Australia: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Australia: Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Australia: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Australia: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Australia: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Recent Inorganic Growth Strategies in the Transdermal Drug Delivery System Market
  • Table 39. Recent Organic Growth Strategies in the Transdermal Drug Delivery System Market
  • Table 40. Glossary of Terms, Asia Pacific Transdermal Drug Delivery System Market

List Of Figures

  • Figure 1. Asia Pacific Transdermal Drug Delivery System Market Segmentation, By Country
  • Figure 2. Asia Pacific Transdermal Drug Delivery System Market: Key Industry Dynamics
  • Figure 3. Asia Pacific Transdermal Drug Delivery System Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Transdermal Drug Delivery System Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 6. Transdermal Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Drug-in-Adhesive Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Matrix Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Reservoir Membrane Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Vapor Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Transdermal Gels: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Transdermal Sprays: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Others: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 15. Cardiovascular Diseases: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Central Nervous System Disorders: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Pain Management: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Opioid: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Non-Opioid: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Hormonal Applications: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Transdermal Estrogen & Progesterone Therapy: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Testosterone Replacement: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Other Application: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 25. Hospital Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Retail Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Online Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Asia Pacific Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 30. Asia Pacific Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
  • Figure 31. China: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Japan: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. India: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Australia: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. South Korea: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Growth Strategies in the Transdermal Drug Delivery System Market